Compounds > benzyloxycarbonyl-isoleucyl-glutamyl(o-tert-butyl)-alanyl-leucinal

benzyloxycarbonyl-isoleucyl-glutamyl(o-tert-butyl)-alanyl-leucinal and carfilzomib

benzyloxycarbonyl-isoleucyl-glutamyl(o-tert-butyl)-alanyl-leucinal has been researched along with carfilzomib* in 1 studies

Other Studies

1 other study(ies) available for benzyloxycarbonyl-isoleucyl-glutamyl(o-tert-butyl)-alanyl-leucinal and carfilzomib

ArticleYear
Next-generation proteasome inhibitor approved in multiple myeloma.
    Nature biotechnology, 2012, Volume: 30, Issue:11

    Topics: Drug Approval; Humans; Multiple Myeloma; Oligopeptides; United States; United States Food and Drug Administration

2012